# EDGAR Filing Document

**Accession Number:** 0001004724
**File Stem:** 0001641172-25-024662
**Filing Date:** 2025-8
**Character Count:** 4340
**Document Hash:** 082a7ed64e2fd97614621382a659e2f9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-024662.hdr.sgml**: 20260522

**ACCESSION NUMBER**: 0001641172-25-024662

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250818

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REGIONAL HEALTH PROPERTIES, INC
- **CENTRAL INDEX KEY:** 0001004724
- **STANDARD INDUSTRIAL CLASSIFICATION:** LESSORS OF REAL PROPERTY, NEC [6519]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 815166048
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1050 CROWN POINTE PARKWAY
- **STREET 2:** SUITE 720
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30338
- **BUSINESS PHONE:** 678-869-5116

**MAIL ADDRESS:**
- **STREET 1:** 1050 CROWN POINTE PARKWAY
- **STREET 2:** SUITE 720
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30338

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS, INC
- **DATE OF NAME CHANGE:** 20130530

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS INC
- **DATE OF NAME CHANGE:** 19951208

---

| | |
|:---|:---|
| Troutman Pepper Locke LLP<br> Bank of America Plaza, 600 Peachtree Street NE, Suite 3000<br> Atlanta, GA 30308<br>troutman.com | ![](formcorresp_001.jpg) |

---

**Paul Davis Fancher**

paul.fancher@troutman.com

August 18, 2025

**VIA EDGAR**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Laura McKenzie

---

| | |
|:---|:---|
| **Re:** | **Regional Health Properties, Inc.**<br> **Schedule 14D-9 filed August 1, 2025**<br> **File No. 005-83967** |

---

Dear Ms. McKenzie:

This letter is being submitted in response to the comments provided by the Staff of the Division of Corporation Finance of the United States Securities and Exchange Commission (the "SEC") set forth in your letter dated August 5, 2025 (the "Comment Letter") to Brent Morrison, Chief Executive Officer and President of Regional Health Properties, Inc. (the "Company"), with respect to the Schedule 14D-9 filed on August 1, 2025 (the "14D-9").

We are authorized by the Company to provide the responses contained in this letter on its behalf. The terms "we," "us," and "our" in the responses refer to the Company. For your convenience, we set forth each comment from the Comment Letter in bold typeface and include the Company's response below it. The numbered paragraphs in this letter correspond to the numbered paragraphs of the Comment Letter.

**<u>Schedule 14D-9 filed August 1, 2025</u>**

**<u>Item 4. The Solicitation or Recommendation</u>**

**1.** **We note your disclosure that the Regional Board "did not take a position" with respect to the Offer but also effectively rejected the Offer. Please clarify whether the Regional Board recommends against the Offer or makes no recommendation with respect to the Offer. Refer to Item 1012(a) of Regulation M-A.** 

Company Response:

The Company has filed an amendment to the 14D-9 to clarify that the Company Board has determined to recommend that the Company's shareholders REJECT the Offer. See Item 4 of Amendment No. 1 to the 14D-9.

---

| | |
|:---|:---|
| **United States Securities and Exchange Commission**<br> August 18, 2025<br> Page 2 | ![](formcorresp_002.jpg) |

---

**2.** **Please revise your disclosure to describe the reasons for the Regional Board's recommendation, or lack thereof, with respect to the Offer, not whether the Offer constitutes a Superior Regional Proposal. Refer to Item 1012(b) of Regulation M-A. While the pending merger may inform the Regional Board's position, the reasons section should speak directly to why the Regional Board determined its recommendation as to whether shareholders should tender into the Offer.** 

Company Response:

The Company has filed an amendment to the 14D-9 to describe the reasons for the Company Board's recommendation with respect to the Offer. See Item 4 of Amendment No. 1 to the 14D-9.

The Company appreciates the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call me at (404) 885-3310.

---

| |
|:---|
| Sincerely, |
| */s/ Paul Davis Fancher* |
| Paul Davis Fancher |

---

cc: Brent Morrison (Regional Health Properties, Inc.)